Stuart L. Goldstein, MD, FAAP, FNKF
- Clark D. West Endowed Chair
- Director, Center for Acute Care Nephrology
- Medical Director, Pheresis Service
- Co-Director, Heart Institute Research Core
- Professor, UC Department of Pediatrics
- stuart.goldstein@cchmc.org
- Board Certified
About
Biography
As a pediatric kidney specialist, I treat children and adolescents in all areas of pediatric nephrology. These include general nephrology, acute kidney injury (AKI), dialysis, transplantation and tuberous sclerosis. I also consult on fetal care if there is a problem with the unborn baby’s kidneys.
I was drawn to the field of nephrology by the opportunity it presents to improve the outcomes for children with kidney problems. Working with children and their families, I help patients reach their full potential. Nephrology also allows me to practice across the entire spectrum of pediatric illness, from acute critical care, to chronic care and outpatient care.
My research is focused on short- and long-term outcomes for children who have AKI and those who are at risk for AKI. I’m interested in AKI epidemiology and outcomes, acute renal replacement therapy and investigation of novel urinary AKI biomarkers in the pediatric population.
In 2012, I established Prospective Pediatric AKI Research Group (ppAKI-RG). The ppAKI-RG is comprised of more than 60 centers around the world with the goal of improving outcomes for the child with, or at-risk for, AKI. This consortium focuses on multicentered research studies that are dedicated to understanding and treating AKI in pediatric patients. This group has completed three major, unprecedented national and international studies to accurately characterize pediatric AKI epidemiology, reduce AKI and improve patient outcomes.
I also developed the only pediatric-specific, acute-care nephrology subspecialty fellowship with graduates who are now leaders in the field of pediatric AKI.
MD: Columbia College of Physicians and Surgeons, New York, NY, 1990.
Residency: Baylor College of Medicine, Houston, TX.
Fellowship: Pediatric Nephrology, Children's Hospital, Boston, MA.
Interests
Acute kidney injury; continuous renal replacement therapy; cardio-renal syndrome; nephrotoxic medication associated morbidity
Services and Specialties
Nephrology and Hypertension, Dialysis, End-Stage Renal Disease, Tuberous Sclerosis, Nephrology - Acute Care, Heart, Colorectal Disorders, Fontan Management Clinic
Interests
Acute kidney injury epidemiology and biomarkers; heart failure associated chronic kidney disease; nephrotoxic medication associated acute kidney injury reduction
Research Areas
Cardiology, Nephrology and Hypertension, Heart
Additional Languages
Spanish
Insurance Information
Cincinnati Children's strives to accept a wide variety of health plans. Please contact your health insurance carrier to verify coverage for your specific benefit plan.
Publications
Using Real-World Data to Externally Evaluate Population Pharmacokinetic Models of Dexmedetomidine in Children and Infants. The Journal of Clinical Pharmacology. 2024; 64:963-974.
Derivation and Validation of an Optimal Neutrophil Gelatinase-Associated Lipocalin Cutoff to Predict Stage 2/3 Acute Kidney Injury (AKI) in Critically Ill Children. Kidney International Reports. 2024; 9:2443-2452.
An update on the role of fluid overload in the prediction of outcome in acute kidney injury. Pediatric Nephrology. 2024; 39:2033-2048.
Phoenix Criteria for Pediatric Sepsis and Septic Shock. Journal of the American Medical Association (JAMA). 2024; 331:2049-2050.
An evaluation of the outcomes associated with peritoneal catheter use in neonates undergoing cardiac surgery: A multicenter study. JTCVS Open. 2024; 19:275-295.
Fifteen-year temporal changes in rates of acute kidney injury among children in Denmark. Pediatric Nephrology. 2024; 39:1917-1925.
Increasing Eligibility to Transplant Through the Selective Cytopheretic Device: A Review of Case Reports Across Multiple Clinical Conditions. Transplantation Direct. 2024; 10:e1627.
Cardiac Surgery-Associated Acute Kidney Injury in Neonates Undergoing the Norwood Operation: Retrospective Analysis of the Multicenter Neonatal and Pediatric Heart and Renal Outcomes Network Dataset, 2015-2018. Pediatric Critical Care Medicine. 2024; 25:e246-e257.
Estimating risk of rapid disease progression in pediatric patients with autosomal dominant polycystic kidney disease: a randomized trial of tolvaptan. Pediatric Nephrology. 2024; 39:1481-1490.
Persistent acute kidney injury and fluid accumulation with outcomes after the Norwood procedure: report from NEPHRON. Pediatric Nephrology. 2024; 39:1627-1637.
From the Blog
First Acute Kidney Injury Diagnostic Test Wins FDA Clearance
Stuart L. Goldstein, MD, FAAP, FNKF, Prasad Devarajan, MD12/7/2023
For Continuous Dialysis Nafamostat Shows Similar Efficacy, Lower Toxicity, Lower Costs vs. Citrate
Stuart L. Goldstein, MD, FAAP, FNKF4/5/2022
Better AWAREness of Acute Kidney Injury Could Transform Intensive Care
Stuart L. Goldstein, MD, FAAP, FNKF6/30/2019
7 Things Parents Need To Know About Nephrotoxic Medications
3/10/2016
3333 Burnet Avenue, Cincinnati, Ohio 45229-3026
© 1999-2024 Cincinnati Children's Hospital Medical Center. All rights reserved.
Patient Ratings and Comments
All patient satisfaction ratings and comments are submitted by actual patients and verified by a leading independent patient satisfaction company, NRC Health. Patient identities are withheld to ensure confidentiality and privacy. Only those providers whose satisfaction surveys are administered through Cincinnati Children’s Hospital Medical Center are displayed. Click here to learn more about our survey